Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: a systematic review and meta …
…, K Wang, H Wang, ZT Chai, J Shi, WX Guo… - European Journal of …, 2019 - Elsevier
Background The benefits of adjuvant transarterial chemoembolization (TACE) in hepatocellular
carcinoma (HCC) patients with microvascular invasion (MVI) remain controversial. We …
carcinoma (HCC) patients with microvascular invasion (MVI) remain controversial. We …
[HTML][HTML] Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis
…, XP Zhang, H Wang, ZT Chai, JX Sun, WX Guo… - HPB, 2019 - Elsevier
Background The effect of microvascular invasion (MVI) on the postoperative long-term prognosis
of solitary small hepatocellular carcinoma remains controversial. We compared the long…
of solitary small hepatocellular carcinoma remains controversial. We compared the long…
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus
J Shi, ECH Lai, N Li, WX Guo, J Xue, WY Lau… - Annals of surgical …, 2010 - Springer
Background The role of liver resection in patients with hepatocellular carcinoma (HCC)
accompanying with portal vein tumor thrombus (PVTT) remains controversial. This article aimed …
accompanying with portal vein tumor thrombus (PVTT) remains controversial. This article aimed …
A new classification for hepatocellular carcinoma with portal vein tumor thrombus
J Shi, ECH Lai, N Li, WX Guo, J Xue, WY Lau… - Journal of hepato-biliary …, 2011 - Springer
Background/purpose We aimed to correlate the survival of patients with hepatocellular
carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent partial …
carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent partial …
Postoperative adjuvant transcatheter arterial chemoembolization after R0 hepatectomy improves outcomes of patients who have hepatocellular carcinoma with …
JJ Sun, K Wang, CZ Zhang, WX Guo, J Shi… - Annals of surgical …, 2016 - Springer
Background Microvascular invasion (MiVI) is a major risk factor of survival outcomes after
curative resection for patients with hepatocellular carcinoma (HCC). This study aimed to …
curative resection for patients with hepatocellular carcinoma (HCC). This study aimed to …
[HTML][HTML] Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis
K Wang, WX Guo, MS Chen, YL Mao, BC Sun, J Shi… - Medicine, 2016 - journals.lww.com
Multimodality Treatment for Hepatocellular Carcinoma With Po... : Medicine Multimodality
Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale …
Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale …
[PDF][PDF] An eastern hepatobiliary surgery hospital/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma …
…, LQ Li, TF Wen, L Xu, K Wang, ZT Chai, WX Guo… - …, 2019 - Wiley Online Library
Portal vein tumor thrombus (PVTT) is a significant poor prognostic factor for hepatocellular
carcinoma (HCC). Patients with PVTT limited to a first‐order branch of the main portal vein (…
carcinoma (HCC). Patients with PVTT limited to a first‐order branch of the main portal vein (…
A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection
N Li, ECH Lai, J Shi, WX Guo, J Xue, B Huang… - Annals of surgical …, 2010 - Springer
Background The role of antiviral therapy for patients in the immune-active phase of hepatitis
B virus (HBV) infection who underwent partial hepatectomy for hepatocellular carcinoma (…
B virus (HBV) infection who underwent partial hepatectomy for hepatocellular carcinoma (…
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
…, HM Yu, YQ Cheng, ZH Liu, YY Qin, J Shi, WX Guo… - Nature Medicine, 2024 - nature.com
Hepatocellular carcinoma (HCC), particularly when accompanied by microvascular invasion
(MVI), has a markedly high risk of recurrence after liver resection. Adjuvant immunotherapy …
(MVI), has a markedly high risk of recurrence after liver resection. Adjuvant immunotherapy …
All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer
…, J Shi, H Gao, J Li, J Zhao, L Qiu, J Liu, N Li, W Guo… - Journal of …, 2013 - Elsevier
Background & Aims Systemic chemotherapy serves as an adjuvant treatment for post-operation
patients with hepatocellular carcinoma (HCC), and provides curative option for the …
patients with hepatocellular carcinoma (HCC), and provides curative option for the …